John G. Compton insider trades

Open-market stock purchases and sales by John G. Compton, Director at 20/20 Biolabs, Inc, from SEC Form 4 filings since Feb 19, 2026.

Recent trades

DateStockTradeValue
Feb 19, 2026AIDX 20/20 Biolabs, IncBought (not open market)—

Companies traded

  • AIDX 20/20 Biolabs, Inc: other filings, last Feb 19, 2026

Get free alerts when John G. Compton files a new trade →